bortezomib krka
krka, d.d., novo mesto - bortezomibas - milteliai injekciniam tirpalui - 1 mg - bortezomib
okitask
dompe farmaceutici s.p.a - ketoprofenas - dengtos granulės paketėlyje - 25 mg - ketoprofen
serynox
elme messer lit, uab - diazoto oksidas/deguonis - suslėgtosios medicininės dujos - 50 %/50 % - nitrous oxide, combinations
airbufo forspiro
sandoz d.d. - budezonidas/formoterolio fumaratas dihidratas - dozuoti įkvepiamieji milteliai - 320 µg/9 µg - formoterol and budesonide
byooviz
samsung bioepis nl b.v. - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologai - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
levodopa/carbidopa fairmed
fairmed healthcare gmbh - levodopa/karbidopa - tabletės - 100 mg/25 mg - levodopa and decarboxylase inhibitor
levodopa/carbidopa fairmed
fairmed healthcare gmbh - levodopa/karbidopa - tabletės - 250 mg/25 mg - levodopa and decarboxylase inhibitor
bortezomib stada
stada arzneimittel ag - bortezomibas - injekcinis tirpalas - 2,5 mg/ml - bortezomib
ximluci
stada arzneimittel ag - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologai - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).